References
1. Okano, H., Nakano, T., Ito, R., et al. 2020. The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia. Clin J Gastroenterol 13(2):252-259. doi:10.1007/s12328-019-01024-3.
2. Suzuki, K., Kumagai, I., Yoshida, Y., et al. 2017. Asymptomatic acute hepatitis E in a female patient with ulcerative colitis. Clin J Gastroenterol 10(3):255-260. doi:10.1007/s12328-017-0730-7.
3. Denner, J. 2019. Hepatitis E virus (HEV)-The future. Viruses 11(3):251-261. doi:10.3390/v11030251.
4. Tulen, A. D., Vennema, H., van Pelt, W., Franz, E., Hofhuis, A. 2019. A case-control study into risk factors for acute hepatitis E in the Netherlands, 2015-2017. J Infect 78(5):373-381. doi:10.1016/j.jinf.2019.02.001.
5. Hoofnagle, J. H., Nelson, K. E., Purcell, R. H. 2012. Hepatitis E. N Engl J Med 367(13):1237-1244. doi:10.1056/NEJMra1204512.
6. Zhang, S., Chen, C., Peng, J., et al. 2017. Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection. Aliment Pharmacol Ther 45(5):701-713. doi:10.1111/apt.13938.
7. Khuroo, M. S., Kamili, S. 2003. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 10(1):61-69. doi:10.1046/j.1365-2893.2003.00398.x.
8. Patra, S., Kumar, A., Trivedi, S. S., Puri, M., Sarin, S. K. 2007. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 147(1):28-33. doi:10.7326/0003-4819-147-1-200707030-00005.
9. Takahashi, M., Kusakai, S., Mizuo, H., et al. 2005. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 43(1):49-56. doi:10.1128/JCM.43.1.49-56.2005.
10. Chau, K. H., Dawson, G. J., Bile, K. M., Magnius, L. O., Sjogren, M. H., Mushahwar, I. K. 1993. Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J Med Virol 40(4):334-338. doi:10.1002/jmv.1890400414.
11. Clayson, E. T., Myint, K. S. A., Snitbhan, R., et al. 1995. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis 172(4):927-933. doi:10.1093/infdis/172.4.927.
12. Dawson, G. J., Chau, K. H., Cabal, C. M., Yarbough, P. O., Reyes, G. R., Mushahwar, I. K. 1992. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 38(1):175-186. doi:10.1016/0166-0934(92)90180-l.
13. Nomura, M., Imai, M., Tsuda, F., et al. 1985. Immunoglobulin A antibody against hepatitis B core antigen in the acute and persistent infection with hepatitis B virus. Gastroenterology 89(5):1109-1113. doi:10.1016/0016-5085(85)90217-3.
14. Yoshizawa, H., Itoh, Y., Iwakiri, S., et al. 1980. Diagnosis of type A hepatitis by fecal IgA antibody against hepatitis A antigen. Gastroenterology 78(1):114-118. doi:10.1016/0016-5085(80)90200-0.
15. Inagaki, Y., Oshiro, Y., Tanaka, T., et al. 2015. A Nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan. Ebiomedicine 2(11):1607-1612. doi:10.1016/j.ebiom.2015.09.030.
16. Hartl, J., Otto, B., Madden, R. G., et al. 2016. Hepatitis E seroprevalence in Europe: A meta-analysis. Viruses 8(8):211. doi:10.3390/v8080211.